Here is yet another day when an ARK Invest exchange-traded fund run by ETF star Cathie Wood parted with even more Pfizer Inc. (NYSE: PFE) shares. Specifically, the fund sold over 400,000 more shares, as the price of this ETF was flat in the day’s session. However, it is up in the past year.
[in-text-ad]
It was ARK Genomic Revolution ETF (NYSEARCA: ARKG) that shed 407,075 shares of Pfizer. At Thursday’s closing price, this would have valued this sale at roughly $20.4 million. This is only a small fraction of the total holdings. The fund is up about 1.5% over the past 52 weeks.
Check out all the ARK Invest sales for Thursday:
Fund | Ticker | Name | Shares |
---|---|---|---|
ARKG | VEEV | VEEVA SYSTEMS | 22,606 |
ARKG | REGN | REGENERON PHARMACEUTICALS | 15,885 |
ARKG | PFE | PFIZER | 407,075 |
ARKG | NSTG | NANOSTRING TECHNOLOGIES | 752 |
ARKG | IOVA | IOVANCE BIOTHERAPEUTICS | 70,800 |
ARKG | CLLS | CELLECTIS | 18,107 |
ARKG | CDXS | CODEXIS | 34,243 |
ARKK | Z | ZILLOW | 137,710 |
ARKK | U | UNITY SOFTWARE | 443,473 |
ARKK | PRLB | PROTO LABS | 29,096 |
ARKK | NSTG | NANOSTRING TECHNOLOGIES | 1,050 |
ARKK | COIN | COINBASE GLOBAL | 124,316 |
ARKW | COIN | COINBASE GLOBAL | 31,658 |
ARKW | PYPL | PAYPAL HOLDINGS | 100 |
ARKW | U | UNITY SOFTWARE | 57,398 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of a673b.bigscoots-temp.com.
Travel Cards Are Getting Too Good To Ignore
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.